Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Intercure stock

Learn how to easily invest in Intercure stock.

Israeli cannabis producer Intercure has applied to have its stock listed on the Nasdaq. The stock is currently listed on the Toronto Stock Exchange under the ticker symbol "INCR:U" and on the Tel Aviv Stock Exchange under the ticker symbol "INCR." If accepted, the stock will trade on the Nasdaq under the same symbol.

We'll update this page as new information becomes available.

How to buy Intercure stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – INCR. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Intercure stock price (NASDAQ: INCR)

Use our graph to track the performance of INCR stocks over time.

Intercure shares at a glance

Information last updated 2023-01-31.
Latest market close$3.72
52-week range$3.27 - $8.20
50-day moving average $4.22
200-day moving average $5.26
Wall St. target price$33.70
PE ratio 16.3636
Dividend yield $0 (0%)
Earnings per share (TTM) $0.22

Buy Intercure stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Intercure stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Intercure price performance over time

Historical closes compared with the close of $3.72 from 2023-02-01

1 week (2023-01-26) -0.53%
1 month (2022-12-30) 12.73%
3 months (2022-11-02) -24.24%
6 months (2022-08-02) -39.61%
1 year (2022-02-02) -41.97%
2 years (2021-02-02) 118.82%
3 years (2020-01-30) 200.00%
5 years (2018-01-29) N/A

Is Intercure stock undervalued or overvalued?

Valuing Intercure stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Intercure's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Intercure's P/E ratio

Intercure's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Intercure shares trade at around 16x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Intercure's P/E ratio is best considered in relation to those of others within the drug manufacturers-specialty & generic industry or those of similar companies.

Intercure financials

Gross profit TTM $102.6 million
Return on assets TTM 5.38%
Return on equity TTM 7.36%
Profit margin 9.15%
Book value N/A
Market capitalisation $164.1 million

TTM: trailing 12 months

Intercure share dividends

We're not expecting Intercure to pay a dividend over the next 12 months.

Have Intercure's shares ever split?

Intercure's shares were split on a 946:4209 basis on 8 April 2021. So if you had owned 4209 shares the day before before the split, the next day you'd have owned 946 shares. This wouldn't directly have changed the overall worth of your Intercure shares – just the quantity. However, indirectly, the new 344.9% higher share price could have impacted the market appetite for Intercure shares which in turn could have impacted Intercure's share price.

Intercure share price volatility

Over the last 12 months, Intercure's shares have ranged in value from as little as $3.27 up to $8.2. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intercure's is -0.2095. This would suggest that Intercure's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Intercure has bucked the trend.

To put Intercure's beta into context you can compare it against those of similar companies.

Intercure overview

InterCure Ltd. , together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel. .

Frequently asked questions

What percentage of Intercure is owned by insiders or institutions?
Currently 37.636% of Intercure shares are held by insiders and 11.507% by institutions.
How many people work for Intercure?
Latest data suggests 350 work at Intercure.
When does the fiscal year end for Intercure?
Intercure's fiscal year ends in December.
Where is Intercure based?
Intercure's address is: 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670
What is Intercure's ISIN number?
Intercure's international securities identification number is: IL0011063760

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site